Multivariate survival analyses on two neuroblastoma cohorts (Kocak GSE45547; SEQC GSE62564) that incorporated MYCN amplification, patient age and tumor stage as other prognostic variables, indicated that high ATP13A3 expression is an independent prognostic marker for neuroblastoma outcome (Table 1). This evidence concerns the gene ATP13A3 and neoplasm.